Acylated insulin compound
The presently described compounds relate to the treatment of diabetes and/or hyperglycemia. More particularly, the described compounds relate to acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such compounds, therapeutic uses of such compounds, and an intermediate compound used to make the acylated insulin compounds.
Eli Lilly and Company
A A A C A
A61K A61K A61P C07K A61K
additional inventional inventional inventional inventional
Adam Robert Francisco Alcides Wen
Mezo Valenzuela Liu